APLS Q2 2020 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

APLSApellis Pharmaceuticals, Inc.

$2B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$122,000

Operating Income

-$116M

Net Income

-$119M

EPS (Diluted)

$-1.57

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$94M

Free Cash Flow

-$95M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$870M

Total Liabilities

$638M

Stockholders' Equity

$232M

Cash & Equivalents

$317M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$122,000	-$63M	+99.8%
Operating Income	-$116M	-$63M	-82.0%
Net Income	-$119M	-$71M	-66.9%